An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.
Gillis CarriganSamuel WhippleMichael D TaylorAracelis Z TorresAnala GossaiBrandon ArnieriMelisa TuckerPhilip P HofmeisterPeter LambertSandra D GriffithWilliam B CapraPublished in: Pharmacoepidemiology and drug safety (2019)
The impact on survival analysis is minimal with high mortality sensitivity with only modest impact associated within external control arm applications.
Keyphrases
- advanced non small cell lung cancer
- electronic health record
- end stage renal disease
- ejection fraction
- epidermal growth factor receptor
- chronic kidney disease
- newly diagnosed
- adverse drug
- prognostic factors
- peritoneal dialysis
- free survival
- type diabetes
- clinical decision support
- cardiovascular disease
- patient reported